MedTrace Logo

The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis

NCT02520401 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-02-15

No results posted yet for this study

Summary

This studies aims to investigate the effect of a probiotics in peri-implantitis patients as an adjunct to non-surgical therapy.

Conditions

  • Peri-implantitis

Interventions

OTHER

Probiotic - BioGaia

Use of a probiotic tablet

OTHER

Placebo

Use of a placebo tablet

Sponsors & Collaborators

  • BioGaia AB

    collaborator INDUSTRY

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02520401 on ClinicalTrials.gov